InvestLog
MDAI Spectral AI, Inc. logo

MDAI Spectral AI, Inc.

Healthcare
$2.68+1.52%ClosedMarket Cap: $85.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-9.66

P/S

5.11

EV/EBITDA

-8.70

DCF Value

$-6.71

FCF Yield

-9.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

44.7%

Operating Margin

-59.4%

Net Margin

-85.6%

ROE

179.2%

ROA

-80.6%

ROIC

-876.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$4.0M$-3.4M$—
Q4 null$3.8M$642.0K$—
FY null$19.6M$-7.6M$—
Q3 null$3.8M$-3.6M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$3.50

Target (Median)

$3.50

Target Range

$3.50 - $3.50

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
BTIGBuy
2026-03-25
BTIGBuy
2026-02-10
BTIGBuy
2025-11-12

Trading Activity

Insider Trades

View All
Sadagopan Deepakdirector
SellWed May 20
DiMaio John Michaeldirector
SellMon May 18
DiMaio John Michaeldirector
SellMon May 18
Cotton Richard Johndirector
SellMon May 18
Cotton Richard Johndirector
SellMon May 18

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

—

Beta

1.16

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

Peers

COEP logoCOEPCTSO logoCTSOECOR logoECOREQ logoEQICCM logoICCMIPSC logoIPSCKPTI logoKPTISRTS logoSRTSTELA logoTELATELO logoTELO